Mei J, Cai Y, Chen L, Wu Y, et al. The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer. Br J Cancer 2023 Sep 15. doi: 10.1038/s41416-023-02432.
PMID: 37715025